BRCA-associated breast cancer in young women

Journal of Clinical Oncology

Volumn 16, Issue 5, 1998, Pages 1642-1649

  Robson, Mark ^a   Gilewski, Teresa ^a   Haas, Bruce ^a   Levin, Deborah ^a   Borgen, Patrick ^a   Rajan, Prabha ^a   Hirschaut, Yashar ^a   Pressman, Peter ^a   Rosen, Paul Peter ^a   Lesser, Martin L ^a   Norton, Larry ^a   Offit, Kenneth ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER GRADING; CANCER SURVIVAL; FEMALE; GENE MUTATION; HETEROZYGOSITY; HISTOPATHOLOGY; HUMAN; JEW; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031860462     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.5.1642     Document Type: Article

References (45)

1. Landis SH, Murray T, Bolden S, et al: Cancer statistics, 1997. CA Cancer J Clin 48:6-30, 1998
2. Claus EB, Schildkraut JM, Thompson WD, et al: The genetic attributable risk of breast and ovarian cancer. Cancer 77:2318-2324, 1996
3. Ford D, Easton DF, Bishop DT, et al: Risks of cancer in BRCA1-mutation carriers. Lancet 343:692-695, 1994
4. Easton DF, Ford D, Bishop DT, et al: Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 56:265-271, 1995
5. Struewing JP, Hartge P, Wacholder S, et al: The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336:1401-1408, 1997
6. Lynch HT, Albano WA, Recabaren JA, et al: Survival in hereditary breast and colon cancer. JAMA 246:1197, 1981
7. Albano WA, Recabaren JA, Lynch HT, et al: Natural history of hereditary cancer of the breast or colon. Cancer 50:360-363, 1982
8. Wobbes TH, van de Wiel MP, van der Sluis RF, et al: The effect of familiality on clinical presentation and survival in mammary carcinoma Eur J Surg Oncol 13:119-121, 1987
9. Fukutomi T, Kobayashi Y, Nanasawa T, et al: A clinicopathologic analysis of breast cancer in patients with a family history. Surg Today 23:849-854, 1993
10. Malone KE, Daling JR, Weiss NS, et al: Family history and survival of young women with invasive breast carcinoma. Cancer 78:1417-1425, 1996
11. Porter DE, Dixon M, Smyth E, et al: Breast cancer survival in BRCA1 carriers. Lancet 341:184-185, 1993
12. Porter DE, Cohen BB, Wallace MR, et al: Breast cancer incidence, penetrance, and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12-21. Br J Surg 81:1512-1515, 1994
13. Marcus JN, Watson P, Page DL, et al: Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer 77:697-709, 1996
14. Jacquemier J, Eisinger F, Birnbaum D, et al: Histoprognostic grade in BRCA1-associated breast cancer. Lancet 345:1503, 1995
15. Eisinger F, Stoppa-Lyonnet D, Longy M, et al: Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer. Cancer Res 56:471-474, 1996
16. Offit K, Gilewski T, McGuire P, et al: Germlme BRCA1 185delAG mutations in Jewish women with breast cancer. Lancet 347:1643-1647, 1996
17. Neuhausen S, Gilewski T, Norton L, et al: Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer Nat Genet 13:126-128, 1996
18. Struewing JP, Abeliovich D, Peretz T, et al: The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 11:198-200, 1995
19. Oddoux C, Streuwing JP, Clayton CM, et al: The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet 14:188-190, 1996
20. Roa BB, Boyd AA, Volcik K, et al: Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 14:185-187, 1996
21. Shattuck-Eidens D, Oliphant A, McClure M, et al: Complete DNA sequence analysis of BRCA1 in 798 women at high risk for susceptibility mutations. JAMA 278:1242-1250, 1997
22. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
23. Robson ME, Offit K: New BRCA2 mutation in an Ashkenazi Jewish family with breast and ovarian cancer. Lancet 350:117, 1997 (letter)
24. Anderson DE, Bazdioch MD: Survival in familial breast cancer patients. Cancer 58:360-365, 1986
25. Ruder AM, Moodie PF, Nelson NA, et al: Does family history of breast cancer improve survival among patients with breast cancer? Am J Obstet Gynecol 158:963-968, 1988
26. Lees AW, Jenkins HJ, May CL, et al: Risk factors and 10-year breast cancer survival in northern Alberta. Breast Cancer Res Treat 13:143-151, 1989
27. Slattery ML, Berry TD, Kerber RA: Is survival among women with breast cancer influenced by a family history of breast cancer? Epidemiology 4:543-548, 1993
28. Israeli D, Tartter PI, Brower ST, et al: The significance of family history for patients with carcinoma of the breast. J Am Coll Surg 179:29-32, 1994
29. Narod S, Tonin P, Lynch H, et al: Histology of BRCA1-associated ovarian tumours. Lancet 343:236, 1994
30. Rubin SC, Benjamin I, Behbakht K, et al: Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N Engl J Med 335:1413-1416, 1996
31. Stratton JF, Gayther SA, Russell P, et al: Contribution of BRCA1 mutations to ovarian cancer. N Engl J Med 336:1125-1130, 1997
32. Johannsson OT, Idvall I, Anderson C, et al: Tumour biological features of BRCA1-induced breast and ovarian cancer. Eur J Cancer 33:362-371, 1997
33. Albain KS, Allred DC, Clark GM: Breast cancer outcome and predictors of outcome: Are there age differentials? JNCI Monogr 16:35-42, 1994
34. Fisher CJ, Egan MK, Smith P, et al: Histopathology of breast cancer in relation to age. Br J Cancer 75:593-596, 1997
35. Nixon AJ, Neuberg D, Hayes DF, et al: Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 12:888-894, 1994
36. Vilcoq JR, Calle R, Stecay P, et al: The outcome of treatment by tumorectomy and radiotherapy of patients with operable breast cancer. Int J Radiat Oncol Biol Phys 7:1327-1332, 1981
37. Kurtz JM, Spitalier J-M, Amalric R, et al: Mammary recurrences in women younger than forty. Im J Radiat Oncol Biol Phys 15:271-276, 1988
38. Matthews RH, McNeese MD, Montague ED, et al: Prognostic implications of age in breast cancer patients treated with tumorectomy and irradiation or with mastectomy. Int J Radiat Oncol Biol Phys 14:659-663, 1988
39. Fourquet A, Campana F, Zafrani B, et al: Prognostic factors of breast recurrence in the conservative management of early breast cancer: A 25-year follow-up. Int J Radiat Oncol Biol Phys 17:719-725, 1989
40. Boyages J, Recht A, Connolly JL, et al: Early breast cancer: Predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. Radiother Oncol 19:29-41, 1990
41. Haffty BG, Fischer D, Rose M, et al: Prognostic factors for local recurrence in the conservatively treated breast cancer patient: A cautious interpretation of the data. J Clin Oncol 9:997-1003, 1991
42. Fisher ER, Anderson S, Redmond C, et al: Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: Pathological findings from NSABP protocol B-06. Semin Surg Oncol 8-161-166, 1992
43. Borger J, Kemperman H, Hart A, et al: Risk factors in breast-conservation therapy. J Clin Oncol 12:653-666, 1994
44. Burke W, Daly M, Garber J, et al: Recommendations for follow-up care of individuals with an inherited predisposition to cancer: II. BRCA1 and BRCA2. JAMA 277:997-1003, 1997
45. Hartmann L, Jenkins R, Schaid D, et al: Prophylactic mastectomy (PM): Preliminary retrospective cohort analysis. Proc Am Assoc Cancer Res 38:168, 1997 (abstr 1123)